Dissolved and financials
CVR: 39434520
Previous names: Locimune IVS, VaccImmune IVS
DKK 22,188
Gross profit
Net result: DKK 22,188
No owners listed
CVR · view owners
No management registered
CVR · view management
Dissolved
Ceased 17 November 2021
CVR · view overview
0 employees
Annual report 2020 · average
Director role ended: Anders Rubinstein
CVR · 17/11/2021
View the full event history
VaccImmune ApS was a Danish company of the type Anpartsselskab based in Nivå, founded in 2018. The company has been dissolved on 17 November 2021. The company was registered under the industry Ikke-finansielle holdingselskaber. The company was previously named VaccImmune IVS and Locimune IVS. According to the 2020 annual report, the company had an average of 0 employees. In 2020, the company reported a gross profit of DKK 22,188 and a net result of DKK 22,188 compared with DKK -11,706 the year before. Equity in the 2020 report amounted to DKK 1.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202001/01/2020 – 31/12/2020 | 22 t. | 22 t. | 19 t. | 1 | 0 | |
| 201901/01/2019 – 31/12/2019 | - | -12 t. | 185 t. | -22 t. | 0 |
Screen owners and management against the Danish FSA's official PEP lists
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorNo. VaccImmune ApS is registered in the Danish CVR register with the status Dissolved and ceased on 17 November 2021.
The CVR number of VaccImmune ApS is 39434520.
In 2020, VaccImmune ApS reported a gross profit of DKK 22,188.
VaccImmune ApS had an average of 0 employees in the 2020 financial year according to the annual report.
VaccImmune ApS was founded on 12 March 2018.
VaccImmune ApS was registered under the industry Ikke-finansielle holdingselskaber (industry code 642020).
As of November 17, 2021, Anders Rubinstein has stepped down as liquidator of VaccImmune ApS.
On November 17, 2021, VaccImmune ApS exited liquidation.
VaccImmune ApS was dissolved on November 17, 2021.
VaccImmune ApS has published its annual report for 2020. Gross profit came to DKK 22,188, and the net result was DKK 22,188.
On October 13, 2021, the company changed its name from VaccImmune IVS to VaccImmune ApS.
As of September 24, 2021, Anders Rubinstein is registered as liquidator of VaccImmune ApS.
On September 24, 2021, VaccImmune ApS entered liquidation.
As of August 30, 2021, Anders Rubinstein has stepped down as liquidator of VaccImmune ApS.
On August 30, 2021, VaccImmune ApS exited liquidation.
As of September 8, 2020, Anders Rubinstein is registered as liquidator of VaccImmune ApS.
As of September 8, 2020, Morten Albrechtsen has stepped down as adm. dir. of VaccImmune ApS.
On September 8, 2020, VaccImmune ApS entered liquidation.
VaccImmune ApS has published its annual report for 2019. The net result was DKK -11,706.
VaccImmune ApS has published its interim report for the period March 12, 2018 to December 31, 2018.
On May 1, 2018, the company changed its name from Locimune IVS to VaccImmune IVS.
As of March 12, 2018, Morten Albrechtsen is registered as adm. dir. of VaccImmune ApS.
VaccImmune ApS was founded on March 12, 2018.
